Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study
Alzheimer's & Dementia · 2023
DOI: 10.1002/alz.13367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2023. Verfasst von Héléne T Cronjé und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Dementia. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NINDS NIH HHS.
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
INTRODUCTION Circulating neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) have been independently associated with dementia risk. Their additive association, and their associations with dementia‐specific mortality, have not been investigated. METHODS We associated serum NfL, GFAP, total tau ,and ubiquitin carboxyl‐terminal hydrolase‐L1, measured in 1712 dementia‐free adults, with 19‐year incident dementia and dementia‐specific mortality risk, and with 3‐year cognitive decline. RESULTS In adjusted models, being in the highest versus lowest tertile of NfL or GFAP associated with a hazard ratio (HR) of 1.49 (1.20–1.84) and 1.38 (1.15–1.66) for incident dementia, and 2.87 (1.79–4.61) and 2.76 (1.73–4.40) for dementia‐specific mortality. Joint third versus first tertile exposure further increased risk; HR = 2.06 (1.60–2.67) and 9.22 (4.48–18.9). NfL was independently associated with accelerated cognitive decline. DISCUSSION Circulating NfL and GFAP may, independently and jointly, provide useful clinical insight regarding dementia risk and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
- Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA.
- Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas, San Antonio, Texas, USA.
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA.
- Departments of Neurology and Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Héléne T Cronjé
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- Alzheimer's Association
- National Heart, Lung, and Blood Institute
- National Institute on Aging
- Novo Nordisk Fonden
Zitieren
APA
Cronjé, H. T., Liu, X., Odden, M. C., Moseholm, K. F., Seshadri, S., Satizabal, C. L., Lopez, O. L., Bis, J. C., Djoussé, L., Fohner, A. E., Psaty, B. M., Tracy, R. P., Longstreth, W. T., Jensen, M. K., & Mukamal, K. J. (2023). Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13367
Vancouver
Cronjé HT, Liu X, Odden MC, Moseholm KF, Seshadri S, Satizabal CL, et al. Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study. Alzheimer's & Dementia. 2023. doi:10.1002/alz.13367
BibTeX
@article{Cronj2023,
author = {Cronjé, Héléne T and Liu, Xiaojuan and Odden, Michelle C and Moseholm, Kristine F and Seshadri, Sudha and Satizabal, Claudia L and Lopez, Oscar L and Bis, Joshua C and Djoussé, Luc and Fohner, Alison E and Psaty, Bruce M and Tracy, Russell P and Longstreth, W T and Jensen, Majken K and Mukamal, Kenneth J},
title = {Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study},
journal = {Alzheimer's & Dementia},
year = {2023},
doi = {10.1002/alz.13367}
}
EUVIMED